Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.35 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL5745536 | 1.00 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL27544253 | 1.00 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL6310117 | 1.00 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL7528671 | 1.00 | SLC34A1 (0.82) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL7623899 | 0.96 | SLC34A1 (0.75) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL7530569 | 0.95 | SLC34A1 (0.90) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL2954685 | 0.95 | SLC34A1 (0.90) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL5907878 | 0.95 | SLC34A1 (0.90) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL2127340 | 0.95 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL5293558 | 0.95 | SLC34A1 (0.90) | SLC34A1KDM4ECYP2C19KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 629 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118236346-A | Lung-targeted ionizable lipid nanoparticle, and preparation method and application thereof | 北京科技大学 | 2024-06-25 | — | — | CN | claimed |
| WO-2024119609-A1 | POLYPEPTIDE DERIVATIVE AND PREPARATION METHOD THEREFOR | 杭州先为达生物科技股份有限公司 | 2024-06-13 | — | — | WO | claimed |
| WO-2024092879-A1 | HIGH-SPECIFICITY ENTEROKINASE DIGESTION METHOD AND USE OF ETHANOL IN IMPROVING ENTEROKINASE DIGESTION SPECIFICITY | 杭州先为达生物科技股份有限公司 | 2024-05-10 | — | — | WO | claimed |
| CN-114181210-B | Preparation method of tetrahydrofolic acid | 深圳奥萨制药有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-111321130-B | Method for improving thermal stability of phospholipase C | 丰益(上海)生物技术研发中心有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-117024950-B | Flame-retardant modified high-fluidity nylon 6 composite material and preparation method thereof | 广州诺森新材料科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117731652-A | Rabies vaccine protective agent and preparation method of vaccine containing rabies vaccine protective agent | 天津中逸安健生物科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| US-20240091146-A1 | STABLE LIQUID PHARMACEUTICAL COMPOSITION CONTAINING KUDING SAPONIN COMPOUND | Shanghai KE Pharmaceutical Co., Ltd (CN) | 2024-03-21 | — | — | US | claimed |
| CN-115612114-B | Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof | 中国科学院天津工业生物技术研究所 | 2024-02-20 | — | — | CN | claimed |
| CN-117567472-A | Synthesis method of 5-methyltetrahydrofolate | 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) | 2024-02-20 | — | — | CN | claimed |
| CN-106727590-A | A kind of suction of stabilization theophylline acetic acid ambroxol solution | 石家庄学院 | 2017-05-31 | — | — | CN | claimed |
| CN-106645344-A | Preparation method and application of deoxynivalenol (DON) electrochemical sensor | 湖南科技大学 | 2017-05-10 | — | — | CN | claimed |
| CN-106538599-A | A kind of stable chlorite compositions and preparation method thereof | 东北大学秦皇岛分校 | 2017-03-29 | — | — | CN | claimed |
| CN-104946134-B | A kind of preparation method of stable high solids content oil-in-water emulsion | 江苏四新科技应用研究所股份有限公司 | 2017-03-01 | — | — | CN | claimed |
| CN-104111244-B | A kind of method of fluoroscopic examination silver ion content | 中国科学院化学研究所 | 2016-08-24 | — | — | CN | claimed |
| CN-105819460-A | Hydrogen-type pillared saponite and preparation method and application thereof | 神华集团有限责任公司 | 2016-08-03 | — | — | CN | claimed |
| CN-105801683-A | Dog interferon freeze-dried product | 天津瑞普生物技术股份有限公司 | 2016-07-27 | — | — | CN | claimed |
| CN-103881088-B | A kind of responsive polymer micelle medicine carrying system and preparation method thereof | 中国科学院长春应用化学研究所 | 2016-07-06 | — | — | CN | claimed |
| CN-103667174-B | A kind of composition for the treatment of biological specimen | 北京东方华辉生物医药科技有限公司 | 2016-06-22 | — | — | CN | claimed |
| US-20120302731-A1 | PROTEIN HYDROLYSATE, POLYPEPTIDE SOLUTION AND POLYPEPTIDE, PREPARATION METHOD AND USE THEREOF | SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) | 2012-11-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240091146-A1 | STABLE LIQUID PHARMACEUTICAL COMPOSITION CONTAINING KUDING SAPONIN COMPOUND | KCND2, TAF9, RPS29 | SLC34A1 2056/4885KDM4E 254/4885CYP2C19 642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.